Stock MNOV MEDICINOVA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus MediciNova, Inc.

Equities

MNOV

US58468P2065

Delayed Nasdaq
Other stock markets
 12:53:04 2024-04-19 pm EDT 		5-day change 1st Jan Change
1.39 USD -0.71% Intraday chart for MediciNova, Inc. -11.46% -7.33%
Mar. 27 MediciNova, Inc. Receives a Notice of Allowance for a New Patent Covering MN-166 for the Treatment of Macular Injury in Japan CI
Mar. 12 Medicinova Announces New Data and Results of Mn-166 in Chlorine Gas-Induced Acute Lung Injury Presented At the 63Rd Annual Meeting of the Society of Toxicology CI

Evolution of the average Target Price on MediciNova, Inc.

Price target over the last 5 years

History of analyst recommendation changes

10065b310b6514c22c156778.V4vXiNXrNWAznUANPSGVtwSD-1s5lnsosF4QbBFaqEc.Zc7i55GlRwZ75DM9THvjgnTZsShd1xh6_G0nIGED0AMA85LM4ttkOkmwIw~725e64e9db108f81db1b32aa9ae9123e

Analyst Recommendations on MediciNova, Inc.

MediciNova Says Alcohol-Use Disorder Drug Reduced Rates of Heavy Drinking, Alcohol Craving in Mid-Stage Trial MT
Maxim Group Adjusts MediciNova Price Target to $6 From $10, Maintains Buy Rating MT
B. Riley Lowers MediciNova's Price Target to $6 from $11 After Revising Cost Capital Assumptions, Keeps Buy Rating MT
MEDICINOVA : Maxim Starts MediciNova at Buy With $15 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.4 USD
Average target price
17 USD
Spread / Average Target
+1,114.29%
High Price Target
28 USD
Spread / Highest target
+1,900.00%
Low Price Target
6 USD
Spread / Lowest Target
+328.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MediciNova, Inc.

Maxim
B. Riley

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MNOV Stock
  4. Consensus MediciNova, Inc.